DZ2548A1 - Compositions de sertraline solubilisée. - Google Patents

Compositions de sertraline solubilisée.

Info

Publication number
DZ2548A1
DZ2548A1 DZ980158A DZ980158A DZ2548A1 DZ 2548 A1 DZ2548 A1 DZ 2548A1 DZ 980158 A DZ980158 A DZ 980158A DZ 980158 A DZ980158 A DZ 980158A DZ 2548 A1 DZ2548 A1 DZ 2548A1
Authority
DZ
Algeria
Prior art keywords
compositions
solubilized
solubilized sertraline
sertraline compositions
sertraline
Prior art date
Application number
DZ980158A
Other languages
English (en)
French (fr)
Inventor
Dwayne Thomas Friesen
Scott Max Herbig
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2548(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2548A1 publication Critical patent/DZ2548A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ980158A 1997-07-01 1998-06-30 Compositions de sertraline solubilisée. DZ2548A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
DZ2548A1 true DZ2548A1 (fr) 2003-02-08

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980158A DZ2548A1 (fr) 1997-07-01 1998-06-30 Compositions de sertraline solubilisée.

Country Status (34)

Country Link
EP (1) EP0999829A1 (ja)
JP (1) JP2000514100A (ja)
KR (1) KR100366373B1 (ja)
CN (1) CN1261794A (ja)
AP (1) AP1192A (ja)
AR (3) AR015917A1 (ja)
AU (1) AU742535B2 (ja)
BG (1) BG103918A (ja)
BR (1) BR9810739A (ja)
CA (1) CA2290974C (ja)
CO (1) CO4940495A1 (ja)
DZ (1) DZ2548A1 (ja)
EA (1) EA002481B1 (ja)
HN (1) HN1998000102A (ja)
HR (1) HRP980377A2 (ja)
HU (1) HUP0002236A3 (ja)
ID (1) ID23429A (ja)
IL (1) IL133076A (ja)
IS (1) IS5260A (ja)
MA (1) MA24587A1 (ja)
NO (1) NO996520L (ja)
OA (1) OA11243A (ja)
PA (1) PA8454301A1 (ja)
PE (1) PE97199A1 (ja)
PL (1) PL337804A1 (ja)
SK (1) SK181099A3 (ja)
TN (1) TNSN98124A1 (ja)
TR (1) TR199903297T2 (ja)
TW (1) TW550087B (ja)
UA (1) UA67741C2 (ja)
UY (1) UY25071A1 (ja)
WO (1) WO1999001120A1 (ja)
YU (1) YU68299A (ja)
ZA (1) ZA985708B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02006324A (es) 1999-12-23 2002-12-13 Pfizer Prod Inc Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco.
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
EP1313473A2 (en) 2000-08-30 2003-05-28 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
KR20120116422A (ko) * 2009-12-29 2012-10-22 코와 가부시키가이샤 경구 투여용 의약 조성물
WO2011081117A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用固形医薬組成物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DK0415612T3 (da) * 1989-08-30 1993-12-13 Pfizer Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
BG103918A (en) 2000-07-31
AU742535B2 (en) 2002-01-03
IL133076A (en) 2003-12-10
IS5260A (is) 1999-11-19
CN1261794A (zh) 2000-08-02
CA2290974C (en) 2004-04-27
HUP0002236A3 (en) 2003-12-29
KR100366373B1 (ko) 2003-01-14
CO4940495A1 (es) 2000-07-24
JP2000514100A (ja) 2000-10-24
ID23429A (id) 2000-04-20
TNSN98124A1 (fr) 2005-03-15
HUP0002236A2 (hu) 2003-08-28
EA199900962A1 (ru) 2000-08-28
PE97199A1 (es) 1999-10-05
CA2290974A1 (en) 1999-01-14
SK181099A3 (en) 2000-07-11
NO996520D0 (no) 1999-12-28
EP0999829A1 (en) 2000-05-17
PA8454301A1 (es) 2000-09-29
AP9801280A0 (en) 1998-06-30
MA24587A1 (fr) 1998-12-31
AR015917A1 (es) 2001-05-30
AR040279A2 (es) 2005-03-23
HN1998000102A (es) 1999-01-08
KR20010013365A (ko) 2001-02-26
UA67741C2 (uk) 2004-07-15
ZA985708B (en) 2000-01-10
AU7544898A (en) 1999-01-25
UY25071A1 (es) 2000-12-29
YU68299A (sh) 2002-06-19
EA002481B1 (ru) 2002-06-27
AP1192A (en) 2003-07-23
TR199903297T2 (xx) 2000-07-21
WO1999001120A1 (en) 1999-01-14
OA11243A (en) 2003-07-24
AR040280A2 (es) 2005-03-23
HRP980377A2 (en) 1999-04-30
NO996520L (no) 2000-02-29
BR9810739A (pt) 2000-09-12
TW550087B (en) 2003-09-01
PL337804A1 (en) 2000-09-11
IL133076A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
TR199800375A3 (tr) Selant kompozisyonlari.
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
BR9903578B1 (pt) composiÇÕes de toner.
ID22931A (id) Komposisi-komposisi herbisidal
DE69815565D1 (de) Pestizide Zusammensetzungen
BR9711114A (pt) Composi-{es pesticidas
DE69919953D1 (de) Funktionelle zusammensetzungen
DK1298194T3 (da) Staniolholdige sammensætninger
ATE243416T1 (de) Pestizid-zusammensetzungen
DZ2205A1 (fr) Compositions antifongiques.
MA25306A1 (fr) Compositions de blanchiment.
TR199500796A2 (tr) Deterjan bilesimler.
ID25650A (id) Komposisi-komposisi sampo
MA24305A1 (fr) Compositions de blanchiment.
ATE231685T1 (de) Pestizide zusammensetzungen
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
DZ2548A1 (fr) Compositions de sertraline solubilisée.
BR9903981B1 (pt) compostos e composiÇÕes de fragrancia de metilciclotetradec-5-en-1-onas.
IT1307041B1 (it) Composizione pesticida.
TR199700147A2 (tr) Mikrop öldürücü terkip.
MA24302A1 (fr) Compositions de blanchiment.
ATE234839T1 (de) 4,5-azolo-oxindole
MA24551A1 (fr) W.c.
FI19992526A (fi) Sahakokoonpano